Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
LABS.TOthis companyMediPharm Labs Corp.	CA$0.07	-3.32×	0.76×	0.61×	-2.56×	-3416.7%	31.0%	-18.6%	-18.3%	-23.1%	-23.3%	-20.5%	0.01×	1.62×	-133.46×	2.77×	0.0%	3	-2.72	2	C+
ADK.VDIAGNOS Inc.	CA$0.36	-6.52×	43.19×	453.09×	-7.44×	-103.4%	-182.4%	-6510.6%	-6956.9%	-663.2%	-204.1%	-13.5%	2.04×	-0.26×	-11.06×	1.49×	0.0%	4	-25.01	1	D+
AVCN.TOAvicanna Inc.	CA$0.11	-9.07×	9.08×	1.01×	-12.94×	-14577.3%	50.4%	-10.7%	-11.2%	-100.0%	-22.5%	-5.6%	0×	0.14×	-52.39×	0.86×	0.0%	3	-4.88	2	C
GWAY.CNGreenway Greenhouse Cannabis Corporation	CA$0.08	-8.81×	2.91×	3.02×	82.82×	-4824.0%	2.5%	-19.3%	-34.4%	-33.1%	-6.2%	-8.9%	2.01×	32.35×	-1.17×	0.48×	0.0%	1	-0.99	—	—
IZO.CNIzotropic Corporation	CA$0.13	-9.6×	-3.74×	0×	-16.94×	-159.6%	0.0%	0.0%	0.0%	38.8%	57.4%	-4.1%	-0.55×	-2.05×	-3×	0.06×	0.0%	1	-176.57	2	C
PINK.VPerimeter Medical Imaging AI, Inc.	CA$0.15	-2.19×	7×	12.31×	-2.15×	-8333.9%	44.1%	-561.6%	-560.7%	-319.0%	-281.8%	-33.1%	0.03×	0.19×	-582.58×	1.56×	0.0%	2	-15.24	1	D+
Peer median	—	-8.81×	7×	3.02×	-7.44×	-4824.0%	2.5%	-19.3%	-34.4%	-100.0%	-22.5%	-8.9%	0.03×	0.14×	-11.06×	0.86×	0.0%	2	-15.24	2	—